These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12885506)

  • 21. Overview of local, state, and national government legislation restricting trans fats.
    Assaf RR
    Clin Ther; 2014 Mar; 36(3):328-32. PubMed ID: 24636818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA proposes rules for health claims on dietary supplements.
    Am J Health Syst Pharm; 1998 Jun; 55(12):1239-40. PubMed ID: 9640461
    [No Abstract]   [Full Text] [Related]  

  • 24. Some Food and Drug Administration perspectives of fat and fatty acids.
    Scarbrough FE
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1578S-1580S. PubMed ID: 9129497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revealing trans fats.
    FDA Consum; 2003; 37(5):20-6. PubMed ID: 14666902
    [No Abstract]   [Full Text] [Related]  

  • 26. The hidden fat: trans fat is unlabeled--and unhealthy.
    Consum Rep; 1998 Nov; 63(11):60-1. PubMed ID: 10343051
    [No Abstract]   [Full Text] [Related]  

  • 27. Trans, saturated, and unsaturated fat in foods in the united states prior to mandatory trans-fat labeling.
    Satchithanandam S; Oles CJ; Spease CJ; Brandt MM; Yurawecz MP; Rader JI
    Lipids; 2004 Jan; 39(1):11-8. PubMed ID: 15055229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why is the Food and Drug Administration interested in dietary fatty acids and thrombosis?
    Glinsmann WH
    Am J Clin Nutr; 1992 Oct; 56(4 Suppl):785S. PubMed ID: 1414978
    [No Abstract]   [Full Text] [Related]  

  • 29. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimming trans fat.
    Winterfeld A
    NCSL Legisbrief; 2007; 15(32):1-2. PubMed ID: 17824130
    [No Abstract]   [Full Text] [Related]  

  • 31. To suppress is human, to disclaim divine.
    Czap A
    Altern Med Rev; 1999 Feb; 4(1):3-4. PubMed ID: 9988777
    [No Abstract]   [Full Text] [Related]  

  • 32. Food and Drug Administration's proposed labeling rules for protein.
    Henley EC
    J Am Diet Assoc; 1992 Mar; 92(3):293-4, 296. PubMed ID: 1552126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Oct; 64(206):57700-33. PubMed ID: 11010706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updated estimate of trans fat intake by the US population.
    Doell D; Folmer D; Lee H; Honigfort M; Carberry S
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(6):861-74. PubMed ID: 22439632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trance(s)--music and more].
    Stahl Z; Grotto I; Moran D; Ginsberg A
    Harefuah; 2013 Dec; 152(12):732-6, 751. PubMed ID: 24482999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Food Labeling: Health Claims; Dietary Saturated Fat and Cholesterol and Risk of Coronary Heart Disease. Interim final rule; request for comments.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Dec; 81(243):91716-22. PubMed ID: 28030885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary supplements: a call to action.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):330-2. PubMed ID: 21133740
    [No Abstract]   [Full Text] [Related]  

  • 39. Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34959-69. PubMed ID: 17674485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA ruling dealing with the food labeling of fats and oils.
    Robertson CJ
    Prev Med; 1972 Mar; 1(1):244-7. PubMed ID: 5069009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.